GRI Bio Financials - Benzinga

GRI Bio Inc

GRINASDAQ

Trade with Public

Trade with Public

$1.81

-0.01-0.55%

At close: Sep 16, 5:00 PM EST

$1.81

N/A

After Hours: 7:55 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Dividends Compare Stock Report

GRI Bio Financials

GRI Bio (GRI) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
GRI Bio Q1 EPS $(1.61) Misses $(0.91) Estimate

GRI Bio (NASDAQ:GRI) reported quarterly losses of $(1.61) per share which missed the analyst consensus estimate of $(0.91) by 78.89 percent. This is a 99.01 percent increase over losses of $(162.40) per share from the

Benzinga Newsdesk

PRO
GRI Bio Q3 EPS $(1.28) Misses $(0.93) Estimate

GRI Bio (NASDAQ:GRI) reported quarterly losses of $(1.28) per share which missed the analyst consensus estimate of $(0.93) by 37.63 percent. This is a 88.79 percent increase over losses of $(11.42) per share from the

Benzinga Newsdesk

PRO
GRI Bio Q2 EPS $(1.31), Inline

GRI Bio (NASDAQ:GRI) reported quarterly losses of $(1.31) per share which met the analyst consensus estimate. This is a 97.88 percent increase over losses of $(61.85) per share from the same period last year.

Benzinga Newsdesk

Crude Oil Falls 1%; Meta Earnings Top Views

Avi Kapoor

Nasdaq Surges Over 1%; Microsoft Posts Upbeat Earnings

Avi Kapoor

PRO
GRI Bio Q1 EPS $(5.80) Misses $(4.11) Estimate

GRI Bio (NASDAQ:GRI) reported quarterly losses of $(5.80) per share which missed the analyst consensus estimate of $(4.11) by 41.12 percent. This is a 94.26 percent increase over losses of $(101.05) per share from the

Benzinga Newsdesk